Revolutionizing Drug Development Through Strategic and Evidence-Driven Digital Health Innovations

Digital Health Technologies (DHTs) are currently being implemented in drug development and healthcare settings, ranging from regulatory endorsed to innovative exploratory technological development. As advancements in sensing technologies and their verified and validated use in effective clinical decision-making progress along with the necessary infrastructure to support their integration, we can expect a streamlined and more efficient integration of DHTs across various stages of drug development. This will support areas such as population identification/stratification, dose selection, collection of real-world data and real-world evidence, evidence for effectiveness and safety, and disease management. This session will include a panel discussion to help the audience gain a better understanding of existing applications and opportunities for DHTs in drug development and important considerations for their validation and/or endorsement by regulatory agencies depending on the development stage. The talks will explore diverse technological advancements within DHTs and their utilization across various stages and processes in drug development. Furthermore, we will delve into the synergistic use of DHTs in drug development and clinical care settings.